Bristol-Myers Leads the Pack in Immuno-Oncology; Credit Suisse Sees $10.5B in 2020 Sales

The new batch of cancer drugs designed to harness the body’s immune system to battle tumors has captured the attention of Wall Street, and for good reason. The new therapies could change the treatment landscape for cancer, and provide the industry’s old guard with a new round of blockbusters. The most exciting, and recent approvals […]